CAS 118191-30-3

Br-DIF-1

CAS : 118191-30-3

Br-DIF-1 is a bone cancer drug that has been shown to be an effective antimicrobial peptide against a number of bacteria. It also has inhibitory activities against tumor cells, including leukemia k562 cells. Br-DIF-1 inhibits the proliferation of these cells by binding to the progesterone receptor and estrogen receptors, which are involved in cell growth and differentiation. Br-DIF-1 is also able to block the prognosis of cancer cells by inhibiting their ability to divide.

Formule : C₁₃H₁₆Br₂O₄

Degré de pureté : Min. 95%

Masse moléculaire : 396.07 g/mol

Ref: 3D-TEA19130